TreeFrog’s Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM)

Posted on by

– TreeFrog Therapeutics demonstrates fast, sustained, full motor recovery in preclinical models for Parkinson’s Disease cell therapy program using C-Stem™ proprietary technology[1] – BORDEAUX, France, March 21, 2024 /PRNewswire/ — TreeFrog Therapeutics, a cell therapy development company…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.